From January 1, 2024 to March 31, 2024, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 160,000 shares, representing 41.84% for $1.14 million under the buyback announced on January 25, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6974 USD | +1.07% | -46.35% | -94.59% |
06-28 | Tonix Pharmaceuticals Closes $4 Million Offering | MT |
06-27 | Top Midday Decliners | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-94.59% | 2.92M | |
+2.42% | 95.18B | |
-4.34% | 37.55B | |
+75.79% | 28.2B | |
-14.61% | 15.63B | |
-3.46% | 13.63B | |
-12.31% | 11.5B | |
+184.77% | 10.81B | |
-54.13% | 9.23B | |
+6.22% | 9.09B |
- Stock Market
- Equities
- TNXP Stock
- News Tonix Pharmaceuticals Holding Corp.
- Tranche Update on Tonix Pharmaceuticals Holding Corp.'s Equity Buyback Plan announced on January 25, 2023.